The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2100-2110
Author(s):
Paola Secchiero, Maria Grazia di Iasio, Arianna Gonelli and Giorgio Zauli
Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP
Journal:
Current Topics in Medicinal Chemistry
Volume:
8
Page:
888-904
Author(s):
Steven D. Knight and Cynthia A. Parrish
Novel Molecular-Targeted Therapeutics for the Treatment of Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
470-480
Author(s):
Hiroshi Yasui and Kohzoh Imai
From ImmunoToxins to ImmunoRNases
Journal:
Current Pharmaceutical Biotechnology
Volume:
9
Page:
210-214
Author(s):
Claudia De Lorenzo and Giuseppe D'Alessio
Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
9
Page:
231-234
Author(s):
Jurgen Krauss, Michaela A.E. Arndt, Stefan Dubel and Susanna M. Rybak
Farnesyltransferase Inhibitors: A Detailed Chemical View on an Elusive Biological Problem
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1478-1492
Author(s):
Sergio F. Sousa, Pedro A. Fernandes and Maria Joao Ramos
Measles Virus as An Oncolytic Vector Platform
Journal:
Current Gene Therapy
Volume:
8
Page:
162-175
Author(s):
Boris Blechacz and Stephen J. Russell
Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
Journal:
Current Protein & Peptide Science
Volume:
9
Page:
227-239
Author(s):
H. Yang, K. R. Landis-Piwowar, D. Chen, V. Milacic and Q. P. Dou
Prevention and Treatment of Regimen-Related Mucosal Toxicity
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
3
Page:
68-75
Author(s):
Joanne M. Bowen
Novel Purine Nucleoside Analogues for Hematological Malignancies
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
3
Page:
123-136
Author(s):
Anna Korycka, Ewa Lech-Maranda and Tadeusz Robak